Parallel Phase I studies of daunorubicin given with cytarabine and etoposide with or without the multidrug resistance modulator PSC-833 in previously untreated patients 60 years of age or older with acute myeloid leukemia: results of cancer and leukemia group B study 9420

• LEE E. J.

収録刊行物

• J. Clin. Oncol.

  J. Clin. Oncol. 17 2831-2839, 1999

詳細情報

• CRID: 1570291224721424512
• NII論文ID: 10008064901
• NII書誌ID: AA10638385
• データソース種別:
  • CiNii Articles